Steffen Schmitz-Valckenberg,
MD
Languages Spoken: English, German
Steffen Schmitz-Valckenberg, MD, specializes in clinical and surgical treatment of macular and retinal diseases, including age-related macular degeneration (AMD), and is an expert in high-resolution retinal imaging.
Dr. Schmitz-Valckenberg co-founded and directed the Grading of Digital Fundus Examination Reading Center at the University of Bonn, Germany, where he was the Department of Ophthalmology’s assistant medical director. As an expert in high-resolution retinal and fundus autofluorescence imaging, he has used various imaging techniques to map the stages of decline in AMD. Researchers worldwide use this mapping to measure outcomes during interventional clinical trials.
At Moran, Dr. Schmitz-Valckenberg is directing an ophthalmic image reading center that will play a key role in the Sharon Eccles Steele Center for Translational Medicine's drive to take a new therapy for a prevalent form of AMD into clinical trials.
Dr. Schmitz-Valckenberg holds a Jon M. Huntsman Presidential Chair at the University of Utah and is a prolific researcher with more than 165 publications and 120 peer-reviewed articles. His honors include being named by The Ophthalmologist to its Power List 2017: Top 50 Rising Stars.
Clinical Locations
801-213-3200
801-581-2352
801-585-3937
Specialties
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor |
| Board Certification | European Board of Ophthalmology Medical Association of North Rhine-Ophthalmology |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.7/ 5
Wait time at clinic
4.5/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
May 12, 2022
FARMINGTON HEALTH CENTER
Dr. Volkenberg is clearly a very busy man and there is nothing wrong with how he does his job at all (he's clearly very informed on my eye problem). However. He seemed to be a great hurry when I saw him this time (visit #8 I believe. They had numbed the eye receiving treatment, but the 'cage' they put in place was very painful and I have had a fairly big hemotoma/bruise on my eye ever since. I am concerned because I am scheduled for cataract surgery in June and I will not be happy if this has messed that up at all.
UofU Patient
May 09, 2022
FARMINGTON HEALTH CENTER
As I said before the doctor and his assistant were wonderful. The assistant helped a lot while doctor was injecting the medication in my eyes. I fell like they care about the patients.
UofU Patient
April 30, 2022
FARMINGTON HEALTH CENTER
Good experience
UofU Patient
April 02, 2022
FARMINGTON HEALTH CENTER
I will recommend this to anybody I have talked too.
UofU Patient
March 26, 2022
FARMINGTON HEALTH CENTER
I thank you all for the care that you all have given me during my eyes surgery. Also thanks for the doctors concerns about the right eye that the results were not to good. But thank you for taking care praying it turns out for the best.
UofU Patient
March 14, 2022
FARMINGTON HEALTH CENTER
Dr is always patient and asks if I have any questions. PA is also good at answering questions if asked.
UofU Patient
March 06, 2022
FARMINGTON HEALTH CENTER
Everything was explained very well to me
UofU Patient
March 05, 2022
FARMINGTON HEALTH CENTER
I called the Moran Eye Center because of a referral from my own son [NAME REMOVED]
UofU Patient
February 19, 2022
FARMINGTON HEALTH CENTER
I was very dismayed to discover that what I was originally told - that the treatment was limited to four shots - was false and that the shots will be ongoing.
UofU Patient
February 15, 2022
FARMINGTON HEALTH CENTER
I have had zero discussion about my cataract position. We had a good discussion about my Glaucoma issues. I was expecting a glaucoma procedure ?? Apparently I left the surgery center after having a cataract procedure without discussion ?? Not Happy, It seems like I am looking through a smudge on my apparent New Lens ??
UofU Patient
February 13, 2022
FARMINGTON HEALTH CENTER
There has been no trust created between us, and our doctor. There is his way of doing it, and he did not indicate evidence, that he was open to any other options, then his own.
UofU Patient
January 27, 2022
MORAN EYE CENTER
I will be sure to tell everyone.
UofU Patient
December 20, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Dr. Valckenberg is excellent. I have already referred him to several friends or relatives who have complicated vision problems.
UofU Patient
December 18, 2021
FARMINGTON HEALTH CENTER
Dr. Valckenberg recommended strongly that I lie flat on my back with my face when you're at the ceiling for at least 10 days. That is not normally my preferred sleeping position however I determined if I expected him to do his best I could at least attempt to do my best which I did. At this moment my left eye is starting to respond reasonably well and the bubble has disappeared. I think over some reasonable period of time my left eye will gain clarity which it doesn't completely have today but I have confidence it will
UofU Patient
December 16, 2021
MORAN EYE CENTER
Very comfortable with Dr Valkenberg and his concerns for my "eyes"
UofU Patient
December 07, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
The Drr. Explained my situation so that I understood.
UofU Patient
November 15, 2021
FARMINGTON HEALTH CENTER
The doctor was an expert in retinal disease and repair and seem to be confident in his ability to perform the surgery answer my questions properly
UofU Patient
November 08, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Always answers my questions to my satisfaction.
UofU Patient
October 31, 2021
FARMINGTON HEALTH CENTER
Dr Valckenberg was exceptional in his exam & explanation to me concerning my macular degeneration which has been very scary to me. I'm pleased he is watching out for me as to Its progression.
UofU Patient
October 15, 2021
FARMINGTON HEALTH CENTER
Good
UofU Patient
October 15, 2021
FARMINGTON HEALTH CENTER
Excellent staff. Work very well together
UofU Patient
October 15, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Good
UofU Patient
October 12, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Good Doctor
UofU Patient
October 03, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
I trust this eye doctor. Can't spell his name.
UofU Patient
October 01, 2021
MORAN EYE CENTER
Always good
UofU Patient
September 18, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
My 93 year old mother's vision had slightly improved. All of us were ecstatic!
UofU Patient
August 29, 2021
FARMINGTON HEALTH CENTER
Excellent
UofU Patient
August 21, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Good
UofU Patient
July 13, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Dr. Valckenberg was very thorough and explained my condition and recommended treatments completely and professionally.I appreciated his kind manner and obvious expertise. I would rate him excellent in all of the above questions.
UofU Patient
July 08, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
My doctor was excellent
UofU Patient
June 26, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
All went well.
UofU Patient
June 19, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
good
UofU Patient
June 14, 2021
MORAN EYE CENTER
The nurse/assistant and doctor informed me of every procedure, etc. that they were doing so that was very appreciated and informative.
UofU Patient
June 07, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
The doctor spent a lot of time answering my plethora of questions.
UofU Patient
May 17, 2021
FARMINGTON HEALTH CENTER
The care provider thoroughly explained all the details of the proposed procedure.
UofU Patient
May 03, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
I let that they told me what I needed to know and what we needed to wait for. I have great expectations as I await mynext
UofU Patient
May 01, 2021
FARMINGTON HEALTH CENTER
There were just major decisions to make and it was difficult to do with no real recommendations and a lack of the information I felt I needed.
UofU Patient
April 15, 2021
FARMINGTON HEALTH CENTER
Dr Marc Schmitz-Valckenberg seemed to be in a huge hurry. when I asked him if I could see the pictures of my eyes to compare he said "no" and didn't bother to discuss it any further. while he was examining my eyes with the bright light and magnifying glass I was blinking and he said to stop blinking so much, there was no paparazzi. then he stretched my eye open so wide, it hurt the sides of my eyes. then dr. said "I can't see anything you don't need to ever come back." I will not ever go back to him, but I will follow up with Dr. Shakoor at Moran at UofU and let him decide if he wants to release me from HIS care.
UofU Patient
April 12, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Dr Schmidtz-Valckenberg Was very reassuring. I was very frightened. He was able to put everything into perspective and help me understand what was happening in a way that made it so much easier for me to cope with. By the end of the visit, I was calm and understood all that was going to happen next. Thank you so much doctor!
UofU Patient
March 30, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
I saw this provider for a procedure, but he realized that he couldn't safely do it and therefore didn't do so; which I appreciated. Unfortunately I have to consider other options.
UofU Patient
February 27, 2021
FARMINGTON HEALTH CENTER
Having to pay attention to this incredible doctor, as he does have a German accent, & my hearing isn't the best. haha
UofU Patient
February 25, 2021
FARMINGTON HEALTH CENTER
The entire staff was wonderful from start to finish.
UofU Patient
February 11, 2021
FARMINGTON HEALTH CENTER
I've already referred my wife to see this doctor
UofU Patient
January 30, 2021
UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER
Dr Valkenberg is highly skilled, friendly, AND MOST IMPORTANTLY, he is saving was vision I have in the left eye.
UofU Patient
January 30, 2021
FARMINGTON HEALTH CENTER
excellent experience
UofU Patient
January 30, 2021
FARMINGTON HEALTH CENTER
Can't put into words how much I appreciate this new doctor. I consider he was & is amazing.
UofU Patient
January 14, 2021
FARMINGTON HEALTH CENTER
Dr Valkenburg was very clear and informative
UofU Patient
December 31, 2020
FARMINGTON HEALTH CENTER
Dr Volkenberg was a superior practitioner! I am very grateful for his experience!
UofU Patient
December 24, 2020
FARMINGTON HEALTH CENTER
good
UofU Patient
December 17, 2020
FARMINGTON HEALTH CENTER
good
Steffen Schmitz-Valckenberg, MD, specializes in clinical and surgical treatment of macular and retinal diseases, including age-related macular degeneration (AMD), and is an expert in high-resolution retinal imaging.
Dr. Schmitz-Valckenberg co-founded and directed the Grading of Digital Fundus Examination Reading Center at the University of Bonn, Germany, where he was the Department of Ophthalmology’s assistant medical director. As an expert in high-resolution retinal and fundus autofluorescence imaging, he has used various imaging techniques to map the stages of decline in AMD. Researchers worldwide use this mapping to measure outcomes during interventional clinical trials.
At Moran, Dr. Schmitz-Valckenberg is directing an ophthalmic image reading center that will play a key role in the Sharon Eccles Steele Center for Translational Medicine's drive to take a new therapy for a prevalent form of AMD into clinical trials.
Dr. Schmitz-Valckenberg holds a Jon M. Huntsman Presidential Chair at the University of Utah and is a prolific researcher with more than 165 publications and 120 peer-reviewed articles. His honors include being named by The Ophthalmologist to its Power List 2017: Top 50 Rising Stars.
Academic Locations
John A. Moran Eye Center
801-581-2352
Board Certification and Academic Information
| Academic Departments | Ophthalmology/Visual Sciences
-
Professor |
| Board Certification | European Board of Ophthalmology Medical Association of North Rhine-Ophthalmology |
Research Interests
- Age-related Macular Degeneration
- Retinal Imaging
- Fundus Autofluorescence
- Molecular Imaging
- Structural-Functional Analysis Including Fundus-Controlled Perimetry
Education History
| Professional Medical | Ruprecht-Karls-University Heidelberg Medicine M.D., 2004 |
Selected Publications - Journal Articles
Journal Article
- Schmitz-Valckenberg S, Fleckenstein M, Zouache MA, Pfau M, Pappas C, Hageman JL, Agrn E, Malley C, Keenan TDL, Chew EY, Hageman GS (2022). Progression of Age-Related Macular Degeneration Among Individuals Homozygous for Risk Alleles on Chromosome 1 (CFH-CFHR5) or Chromosome 10 (ARMS2/HTRA1) or Both. JAMA Ophthalmol, 140(3), 252-260.
- Holz FG, Schmitz-Valckenberg S, Wolf A, Agostini H, Lorenz K, Pielen A, Feltgen N, Guthoff R, Quiering C, Clemens A, Jaeger K (2022). A randomized, open-label, multicenter study of switching to brolucizumab with or without a loading dose for patients with suboptimal anatomically controlled neovascular age-related macular degeneration-the FALCON study. Graefes Arch Clin Exp Ophthalmol.
- Knzel SH, Lindner M, Sassen J, Mller PT, Goerdt L, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau M (2022). Association of Reading Performance in Geographic Atrophy Secondary to Age-Related Macular Degeneration With Visual Function and Structural Biomarkers. JAMA Ophthalmol, 139(11), 1191-1199.
- Behning C, Fleckenstein M, Pfau M, Adrion C, Goerdt L, Lindner M, Schmitz-Valckenberg S, Holz FG, Schmid M (2021). Modeling of atrophy size trajectories: variable transformation, prediction and age-of-onset estimation. BMC Med Res Methodol, 21(1), 170.
- von der Emde L, Pfau M, Holz FG, Fleckenstein M, Kortuem K, Keane PA, Rubin DL, Schmitz-Valckenberg S (2021). AI-based structure-function correlation in age-related macular degeneration. Eye (Lond), 35(8), 2110-2118.
- Pfau M, Sahu S, Rupnow RA, Romond K, Millet D, Holz FG, Schmitz-Valckenberg S, Fleckenstein M, Lim JI, de Sisternes L, Leng T, Rubin DL, Hallak JA (2021). Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration. Transl Vis Sci Technol, 10(7), 30.
- Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY (2021). Age-related macular degeneration. Nat Rev Dis Primers, 7(1), 31.
- Holz FG, Oleksy P, Ricci F, Kaiser PK, Kiefer J, Schmitz-Valckenberg S, COLUMBUS-AMD Study Group (2021). Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration. Ophthalmology, 129, 54-63.
- Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2020). Fundus-controlled perimetry (microperimetry): Application as outcome measure in clinical trials. Prog Retin Eye Res, 82, 100907.
- Wu Z, Pfau M, Blodi BA, Holz FG, Jaffe GJ, Liakopoulos S, Sadda SR, Staurenghi G, Bjelopera E, Brown T, Chang P, Choong J, Corradetti G, Corvi F, Domalpally A, Hurtenbach C, Nittala MG, Olson A, Pak JW, Pappe J, Samannshausen M, Skalak C, Thiele S, Guymer RH, Schmitz-Valckenberg S (2021). OCT Signs of Early Atrophy in Age-Related Macular Degeneration: Interreader Agreement: Classification of Atrophy Meetings Report 6. Ophthalmol Retina, 6, 4-14.
- Samannshausen M, Zhou J, Pfau M, Thiele S, Steinberg J, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2020). Longitudinal Analysis of Retinal Thickness and Retinal Function in Eyes with Large Drusen Secondary to Intermediate Age-Related Macular Degeneration. Ophthalmol Retina, 5(3), 241-250.
- Schmitz-Valckenberg S, Pfau M, Fleckenstein M, Staurenghi G, Sparrow JR, Bindewald-Wittich A, Spaide RF, Wolf S, Sadda SR, Holz FG (2020). Fundus autofluorescence imaging. Prog Retin Eye Res, 81, 100893.
- Barkana Y, Pondorfer SG, Schmitz-Valckenberg S, Russ H, Finger RP (2021). Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration. Sci Rep, 11(1), 4764.
- Mller PL, Pfau M, Schmitz-Valckenberg S, Fleckenstein M, Holz FG (2020). Optical Coherence Tomography-Angiography in Geographic Atrophy. Ophthalmologica, 244(1), 42-50.
- Huss MB, Schmitz-Valckenberg S, Finger RP, Lffler KU, Fleckenstein M, Holz FG, Pfau M (2020). The Willingness of Patients to Participate in an Eye Donation Registry for Research. Ophthalmologica, 244(3), 179-186.
- Schmitz-Valckenberg S, Braun MD, Thiele S, Ferrara D, Honigberg L, Gao SS, Chen H, Steffen V, Holz FG, Samannshausen M (2021). Conversion from Intermediate Age-Related Macular Degeneration to Geographic Atrophy in a Proxima B Subcohort Using a Multimodal Approach. Ophthalmologica, 244(6), 523-534.
- Jaffe GJ, Chakravarthy U, Freund KB, Guymer RH, Holz FG, Liakopoulos S, Mons JM, Rosenfeld PJ, Sadda SR, Sarraf D, Schmitz-Valckenberg S, Spaide RF, Staurenghi G, Tufail A, Curcio CA (2020). Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 5. Ophthalmol Retina, 5, 855-867.
- Pfau M, von der Emde L, de Sisternes L, Hallak JA, Leng T, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Rubin DL (2020). Progression of Photoreceptor Degeneration in Geographic Atrophy Secondary to Age-related Macular Degeneration. JAMA Ophthalmol, 138(10), 1026-1034.
- Pfau M, Walther G, von der Emde L, Berens P, Faes L, Fleckenstein M, Heeren TFC, Kortm K, Knzel SH, Mller PL, Maloca PM, Waldstein SM, Wintergerst MWM, Schmitz-Valckenberg S, Finger RP, Holz FG (2020). [Artificial intelligence in ophthalmology : Guidelines for physicians for the critical evaluation of studies]. Ophthalmologe, 117(10), 973-988.
- Pfau M, von der Emde L, Dysli C, Mller PT, Thiele S, Lindner M, Schmid M, Rubin DL, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2020). Determinants of Cone and Rod Functions in Geographic Atrophy: AI-Based Structure-Function Correlation. Am J Ophthalmol, 217, 162-173.
- Sassmannshausen M, Pfau M, Thiele S, Fimmers R, Steinberg JS, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2020). Longitudinal Analysis of Structural and Functional Changes in Presence of Reticular Pseudodrusen Associated With Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 61(10), 19.
- Terheyden JH, Holz FG, Schmitz-Valckenberg S, Lning A, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Snchez CI, Hoyng C, Margaron P, Zakaria N, Durbin M, Luhmann U, Zamiri P, Cunha-Vaz J, Martinho C, Leal S, Finger RP, MACUSTAR consortium (2020). Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR. Trials, 21(1), 659.
- Wachtlin J, Spital G, Schmitz-Valckenberg S, Liakopoulos S, Vgeler J, Mller B, Ziemssen F, Ocean Study Group (2020). Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany. J Ophthalmol, 2020, 8024258.
- Berger M, Schmid M, Welchowski T, Schmitz-Valckenberg S, Beyersmann J (2018). Subdistribution hazard models for competing risks in discrete time. Biostatistics, 21(3), 449-466.
- Meyer JH, Marx J, Strack C, Holz FG, Schmitz-Valckenberg S (2020). Imaging of Therapeutic Effects of Anti-Vascular Endothelial Growth Factor Inhibitors by Optical Coherence Tomography Angiography in a Rat Model. Transl Vis Sci Technol, 9(7), 29.
- Holekamp N, Wykoff CC, Schmitz-Valckenberg S, Mons J, Souied EH, Lin H, Rabena MD, Cantrell RA, Henry EC, Tang F, Swaminathan B, Martin J, Ferrara D, Staurenghi G (2019). Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials. Ophthalmology, 127(6), 769-783.
- Raber FP, Reinking K, Schmitz-Valckenberg S, Althaus K, Kaut O, Witry M, Lang GE (2020). [Successful Systemic Lysis Therapy in Acute Retinal Arterial Occlusions]. Klin Monbl Augenheilkd, 237(6), 772-779.
- Knzel SH, Mller PT, Lindner M, Goerdt L, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau M (2020). Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 61(5), 63.
- Pielen A, Feltgen N, Hattenbach LO, Hoerauf H, Bertelmann T, Quiering C, Vgeler J, Priglinger S, Lang GE, Schmitz-Valckenberg S, Wolf A, Rehak M (2019). Ranibizumab Pro Re nata versus Dexamethasone in the Management of Ischemic Retinal Vein Occlusion: Post-hoc Analysis from the COMRADE Trials. Curr Eye Res, 45(5), 604-614.
- Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, Souied EH, Cohen SY, Querques G, Ohno-Matsui K, Boyer D, Gaudric A, Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A, Singerman L, Luthert P, Schmitz-Valckenberg S, Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ, Guymer R, Yannuzzi LA, Chew EY, Csaky K, Mons JM, Pauleikhoff D, Tadayoni R, Fujimoto J (2019). Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group. Ophthalmology, 127(5), 616-636.
- Schmitz-Valckenberg S, Brasse K, Hoerauf H (2020). [Vitreous floaters]. Ophthalmologe, 117(5), 485-496.
- Wintergerst MWM, Gorgi Zadeh S, Wiens V, Thiele S, Schmitz-Valckenberg S, Holz FG, Finger RP, Schultz T (2020). Replication and Refinement of an Algorithm for Automated Drusen Segmentation on Optical Coherence Tomography. Sci Rep, 10(1), 7395.
- Thiele S, Nadal J, Pfau M, Samannshausen M, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg S (2020). Prognostic value of intermediate age-related macular degeneration phenotypes for geographic atrophy progression. Br J Ophthalmol.
- Schmitz-Valckenberg S, Khlewein L, Waldstein SM, Spital G, Ziemssen F, Liakopoulos S (2020). Second Opinion in Retinal Imaging. Ophthalmologe, 117(4), 326-330.
- Gale RP, Pearce I, Eter N, Ghanchi F, Holz FG, Schmitz-Valckenberg S, Balaskas K, Burton BJL, Downes SM, Eleftheriadis H, George S, Gilmour D, Hamilton R, Lotery AJ, Patel N, Prakash P, Santiago C, Thomas S, Varma D, Walters G, Williams M, Wolf A, Zakri RH, Igwe F, Ayan F (2019). Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study. Br J Ophthalmol, 104(4), 493-499.
- Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, Schmitz-Valckenberg S, Sparrow J, Spaide RF, Tufail A, Chakravarthy U, Jaffe GJ, Csaky K, Sarraf D, Mons JM, Tadayoni R, Grunwald J, Bottoni F, Liakopoulos S, Pauleikhoff D, Pagliarini S, Chew EY, Viola F, Fleckenstein M, Blodi BA, Lim TH, Chong V, Lutty J, Bird AC, Sadda SR (2019). Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology, 127(3), 394-409.
- Pfau M, Mller PT, Knzel SH, von der Emde L, Lindner M, Thiele S, Dysli C, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (2019). Type 1 Choroidal Neovascularization Is Associated with Reduced Localized Progression of Atrophy in Age-Related Macular Degeneration. Ophthalmol Retina, 4(3), 238-248.
- Liakopoulos S, Spital G, Brinkmann CK, Schick T, Ziemssen F, Voegeler J, Koch M, Kirchhof B, Holz FG, Pauleikhoff D, Schmitz-Valckenberg S (2020). ORCA study: real-world versus reading centre assessment of disease activity of neovascular age-related macular degeneration (nAMD). Br J Ophthalmol.
- Thiele S, Nadal J, Pfau M, Samannshausen M, von der Emde L, Fleckenstein M, Holz FG, Schmid M, Schmitz-Valckenberg S, Molecular Diagnostic of Age-related Macular Degeneration Study Group (2019). Prognostic Value of Retinal Layers in Comparison with Other Risk Factors for Conversion of Intermediate Age-related Macular Degeneration. Ophthalmol Retina, 4(1), 31-40.
- von der Emde L, Thiele S, Pfau M, Nadal J, Meyer J, Mller PT, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2019). Assessment of Exudative Activity of Choroidal Neovascularization in Age-Related Macular Degeneration by OCT Angiography. Ophthalmologica, 243(2), 120-128.
- Pfau M, Mller PL, von der Emde L, Lindner M, Mller PT, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). MESOPIC AND DARK-ADAPTED TWO-COLOR FUNDUS-CONTROLLED PERIMETRY IN GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina, 40(1), 169-180.
- Terheyden JH, Finger RP, Schmitz-Valckenberg S, Agostini H, Dahlke C, Kuehlewein L, Lang GE, Pauleikhoff D, Wolf A, Boettger MK, Luhmann UFO, Asmus F, Holz FG, MACUSTAR-Konsortium (2019). [Development and validation of novel clinical endpoints in intermediate age-related macular degeneration in MACUSTAR]. Ophthalmologe, 116(12), 1186-1193.
- Callizo J, Ziemssen F, Bertelmann T, Feltgen N, Vgeler J, Koch M, Eter N, Liakopoulos S, Schmitz-Valckenberg S, Spital G (2019). Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study. Clin Ophthalmol, 13, 2167-2179.
- Pfau M, von der Emde L, Dysli C, Thiele S, Mller PT, Lindner M, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (2019). Light Sensitivity Within Areas of Geographic Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 60(12), 3992-4001.
- Fleckenstein M, Thiele S, Pfau M, Schmitz-Valckenberg S, Holz FG (2019). [Dry Age-Related Macular Degeneration - Epidemiology and Classification]. Klin Monbl Augenheilkd, 236(9), 1068-1075.
- Pfau M, Lindner M, Goerdt L, Thiele S, Nadal J, Schmid M, Schmitz-Valckenberg S, Sadda SR, Holz FG, Fleckenstein M, Fundus Autofluorescence in Age-Related Macular Degeneration Study Group (2018). PROGNOSTIC VALUE OF SHAPE-DESCRIPTIVE FACTORS FOR THE PROGRESSION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION. Retina, 39(8), 1527-1540.
- von der Emde L, Pfau M, Dysli C, Thiele S, Mller PT, Lindner M, Schmid M, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2019). Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration. Sci Rep, 9(1), 11132.
- Meyer JH, Larsen PP, Strack C, Harmening WM, Krohne TU, Holz FG, Schmitz-Valckenberg S (2019). Optical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularization. Exp Eye Res, 184, 162-171.
- Gattoussi S, Buitendijk GHS, Peto T, Leung I, Schmitz-Valckenberg S, Oishi A, Wolf S, Dek G, Delcourt C, Klaver CCW, Korobelnik JF, European Eye Epidemiology E3 consortium (2018). The European Eye Epidemiology spectral-domain optical coherence tomography classification of macular diseases for epidemiological studies. Acta Ophthalmol, 97(4), 364-371.
- Grassmann F, Harsch S, Brandl C, Kiel C, Nrnberg P, Toliat MR, Fleckenstein M, Pfau M, Schmitz-Valckenberg S, Holz FG, Chew EY, Swaroop A, Ratnapriya R, Klein ML, Mulyukov Z, Zamiri P, Weber BHF (2019). Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration. JAMA Ophthalmol.
- Lindner M, Pfau M, Czauderna J, Goerdt L, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (2018). Determinants of Reading Performance in Eyes with Foveal-Sparing Geographic Atrophy. Ophthalmol Retina, 3(3), 201-210.
- Brasse K, Schmitz-Valckenberg S, Jnemann A, Roider J, Hoerauf H (2018). [YAG laser vitreolysis for treatment of symptomatic vitreous opacities]. Ophthalmologe, 116(1), 73-84.
- Finger RP, Schmitz-Valckenberg S, Schmid M, Rubin GS, Dunbar H, Tufail A, Crabb DP, Binns A, Snchez CI, Margaron P, Normand G, Durbin MK, Luhmann UFO, Zamiri P, Cunha-Vaz J, Asmus F, Holz FG, onbehalfoftheMACUSTARconsortium (2018). MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration. Ophthalmologica, 241(2), 61-72.
- Fang PP, Domdei N, Herrmann P, Schmitz-Valckenberg S, Holz FG, Harmening WM, Krohne TU (2017). MINIMAL OPTICAL COHERENCE TOMOGRAPHY B-SCAN DENSITY FOR RELIABLE DETECTION OF INTRARETINAL AND SUBRETINAL FLUID IN MACULAR DISEASES. Retina, 39(1), 150-156.
- Ziemssen F, Wachtlin J, Kuehlewein L, Gamulescu MA, Bertelmann T, Feucht N, Voegeler J, Koch M, Liakopoulos S, Schmitz-Valckenberg S, Spital G, OCEAN study group (2018). Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data from a Non-interventional, Multicenter Study in Germany. Diabetes Ther, 9(6), 2271-2289.
- Pfau M, Lindner M, Gliem M, Steinberg JS, Thiele S, Finger RP, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). Mesopic and dark-adapted two-color fundus-controlled perimetry in patients with cuticular, reticular, and soft drusen. Eye (Lond), 32(12), 1819-1830.
- Feltgen N, Hattenbach LO, Bertelmann T, Callizo J, Rehak M, Wolf A, Berk H, Eter N, Lang GE, Pielen A, Schmitz-Valckenberg S, Quiering C, Rose U, Hoerauf H, COMRADE Study Group (2018). Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study. Acta Ophthalmol, 96(8), e933-e941.
- Brinkmann CK, Chang P, Schick T, Heimes B, Vgeler J, Haegele B, Kirchhof B, Holz FG, Pauleikhoff D, Ziemssen F, Liakopoulos S, Spital G, Schmitz-Valckenberg S (2018). Initial diagnosis and indication for anti-vascular endothelial growth factor therapy in retinal diseases. Ophthalmologe.
- Mller PL, Pfau M, Mauschitz MM, Mller PT, Birtel J, Chang P, Gliem M, Schmitz-Valckenberg S, Fleckenstein M, Holz FG, Herrmann P (2018). Comparison of Green Versus Blue Fundus Autofluorescence in ABCA4-Related Retinopathy. Transl Vis Sci Technol, 7(5), 13.
- Paul C, Krug P, Muller HH, Wachtlin J, Mennel S, Muller S, Schmitz-Valckenberg S, Bertelmann T, Schumann RG (2018). Comparison of the horizontal diameter to a modeled area of traction in eyes with vitreomacular traction: is the diameter close enough to the truth? Graefes Arch Clin Exp Ophthalmol, 256(10), 1817-1822.
- Pfau M, Lindner M, Steinberg JS, Thiele S, Brinkmann CK, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases. Br J Ophthalmol, 102(8), 1054-1059.
- Paul C, Heun C, Mller HH, Hoerauf H, Feltgen N, Wachtlin J, Kaymak H, Mennel S, Koss MJ, Fauser S, Maier MM, Schumann RG, Mueller S, Chang P, Schmitz-Valckenberg S, Kazerounian S, Szurman P, Lommatzsch A, Bertelmann T (2018). Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT study. Br J Ophthalmol, 102(8), 1092-1097.
- Welker SG, Pfau M, Heinemann M, Schmitz-Valckenberg S, Holz FG, Finger RP (2018). Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched Controls. Invest Ophthalmol Vis Sci, 59(4), AMD152-AMD159.
- Mller PL, Pfau M, Mller PT, Nadal J, Schmid M, Lindner M, de Sisternes L, Sthr H, Weber BHF, Neuhaus C, Herrmann P, Schmitz-Valckenberg S, Holz FG, Fleckenstein M (2018). Choroidal Flow Signal in Late-Onset Stargardt Disease and Age-Related Macular Degeneration: An OCT-Angiography Study. Invest Ophthalmol Vis Sci, 59(4), AMD122-AMD131.
- Lindner M, Kosanetzky S, Pfau M, Nadal J, Gordt LA, Schmitz-Valckenberg S, Schmid M, Holz FG, Fleckenstein M (2018). Local Progression Kinetics of Geographic Atrophy in Age-Related Macular Degeneration Are Associated With Atrophy Border Morphology. Invest Ophthalmol Vis Sci, 59(4), AMD12-AMD18.
- Thiele S, Pfau M, Larsen PP, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). Multimodal Imaging Patterns for Development of Central Atrophy Secondary to Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 59(4), AMD1-AMD11.
- Sassmannshausen M, Steinberg JS, Fimmers R, Pfau M, Thiele S, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). Structure-Function Analysis in Patients With Intermediate Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci, 59(3), 1599-1608.
- Hattenbach LO, Feltgen N, Bertelmann T, Schmitz-Valckenberg S, Berk H, Eter N, Lang GE, Rehak M, Taylor SR, Wolf A, Weiss C, Paulus EM, Pielen A, Hoerauf H (2018). Head-to-head comparison of ranibizumab PRN versus single-dose dexamethasone for branch retinal vein occlusion (COMRADE-B). Acta Ophthalmol, 96(1), e10-e18.
- von der Emde L, Pfau M, Thiele S, Mller PT, Hassenrik R, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2018). Mesopic and Dark-Adapted Two-Color Fundus-Controlled Perimetry in Choroidal Neovascularization Secondary to Age-Related Macular Degeneration. Transl Vis Sci Technol, 8(1), 7.
Review
- Terheyden JH, Schmitz-Valckenberg S, Crabb DP, Dunbar H, Luhmann UFO, Behning C, Schmid M, Silva R, Cunha-Vaz J, Tufail A, Weissgerber G, Leal S, Holz FG, Finger RP, onbehalfoftheMACUSTARConsortium (2020). Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions. [Review]. Ophthalmologica, 244(5), 387-395.
- Mller PL, Wolf S, Dolz-Marco R, Tafreshi A, Schmitz-Valckenberg S, Holz FG, Bille JF (2019). Ophthalmic Diagnostic Imaging: Retina. [Review].
Conference Proceedings
Other
- Samannshausen M, Thiele S, Behning C, Pfau M, Schmid M, Leal S, Luhmann UFO, Finger RP, Holz FG, Schmitz-Valckenberg S, MACUSTAR Consortium (2022). Intersession Repeatability of Structural Biomarkers in Early and Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report. Transl Vis Sci Technol (11(3), p. 27). United States.
- Rieck S, Kilgus S, Meyer JH, Huang H, Zhao L, Matthey M, Wang X, Schmitz-Valckenberg S, Fleischmann BK, Wenzel D (2021). Inhibition of Vascular Growth by Modulation of the Anandamide/Fatty Acid Amide Hydrolase Axis. Arterioscler Thromb Vasc Biol (41(12), pp. 2974-2989). United States.
- Pfau M, van Dijk EHC, van Rijssen TJ, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Boon CJF (2021). Estimation of current and post-treatment retinal function in chronic central serous chorioretinopathy using artificial intelligence. Sci Rep (11(1), p. 20446). England.
Global Impact
Education History
| Professional Medical | Ruprecht-Karls-University Heidelberg Medicine M.D. |